The Global Mammography market size was valued at $2,246.1 million in 2022, and is projected to reach $4,718.5 million by 2030, growing at CAGR of 10.26%. The global mammography market refers to the market for diagnostic imaging equipment used for breast cancer screening and diagnosis. Mammography is a type of medical imaging that uses low-dose X-rays to produce images of the breast tissue.

Browse 218 market data Tables and 96 Figures spread through 319 Pages and in-depth TOC on "Mammography Market Size, Share & Trends Estimation Report By Outlook, By Region, And Segment Forecasts, 2022 - 2030" View detailed Table of Content here-https://www.contrivedatuminsights.com/product-report/mammography-market-248686/

The market for mammography equipment and services has been growing steadily over the past decade, driven by factors such as increasing awareness about breast cancer and the importance of early detection, as well as technological advancements in mammography equipment. The increasing incidence of breast cancer, rising geriatric population, and growing demand for minimally invasive procedures are some of the key factors driving market growth.

Market Dynamics

Increasing incidence of breast cancer: Breast cancer is one of the most common types of cancer, and its incidence is increasing globally. This has led to a growing demand for mammography equipment and services for early detection and diagnosis of breast cancer.

Growing awareness about breast cancer: There has been a significant increase in awareness about breast cancer and the importance of early detection. This has led to more women undergoing regular mammography screenings, driving the demand for mammography equipment and services.

High cost of mammography equipment and services: Mammography equipment and services can be expensive, which can limit access to screening and diagnostic services, particularly in low- and middle-income countries.

Risks associated with mammography: Although mammography is considered a safe procedure, there are some risks associated with exposure to ionizing radiation. This can lead to concerns about potential harms associated with regular screening, which may limit its uptake.

Cost and access: As mentioned earlier, the high cost of mammography equipment and services can limit access to screening and diagnostic services, particularly in low- and middle-income countries. Efforts are being made to address this issue, including the development of more affordable mammography equipment and increasing access to screening services in underserved communities.

Technological advancements: While technological advancements in mammography equipment have improved the accuracy and efficiency of breast cancer screening and diagnosis, they can also pose challenges. The development of new equipment and technologies requires significant investments in research and development, which can be a barrier for smaller companies.

Advancements in digital mammography: Digital mammography has the potential to improve the accuracy and efficiency of breast cancer screening and diagnosis, and there is ongoing research and development in this area. Companies can capitalize on this opportunity by investing in research and development to develop new and advanced digital mammography equipment and services.

Personalized medicine: The development of personalized medicine for breast cancer treatment is a growing area of research, and there is potential for companies to develop new technologies and services that support personalized medicine. This could include the development of imaging technologies that provide more precise information about tumor characteristics and response to treatment.

3D mammography (tomosynthesis) technology uses multiple X-ray images to create a three-dimensional image of the breast, which can improve the accuracy of breast cancer detection and reduce the need for additional imaging tests. 3D mammography is becoming increasingly popular, and there are ongoing efforts to develop more advanced 3D mammography technologies.

Breast ultrasound technology uses high-frequency sound waves to create images of the breast. Breast ultrasound is often used as a supplementary imaging test in conjunction with mammography, particularly in women with dense breast tissue.

Ambulatory surgical centers provide outpatient surgical procedures, including breast biopsies, which often require mammography imaging for guidance. Research and academic institutes are involved in breast cancer research and often use mammography equipment for research purposes. Other end-users of mammography equipment and services include government agencies, non-profit organizations, and private clinics.

The market is highly competitive, with several key players including Hologic, Inc., GE Healthcare, Siemens Healthineers, Fujifilm Holdings Corporation, and Koninklijke Philips N.V. These companies are focused on developing new and advanced mammography equipment and services to cater to the growing demand for breast cancer screening and diagnosis.

Regional Analysis

Latin America and the Middle East & Africa are relatively smaller markets for mammography but are expected to witness significant growth over the next few years. The growth in these regions is primarily driven by increasing government initiatives to promote breast cancer screening and improving healthcare infrastructure.

In conclusion, the global mammography market is a highly dynamic and competitive industry, with significant growth potential in all regions of the world. North America is currently the largest market, followed by Europe and Asia-Pacific, with Latin America and the Middle East & Africa expected to witness significant growth over the next few years.

Competitive Analysis

In September 2021, Siemens Healthineers announced that it had completed the acquisition of Varian Medical Systems, a leading provider of radiation oncology solutions, for $16.4 billion. The acquisition is expected to strengthen Siemens' position in the oncology market and help the company expand its portfolio of cancer care solutions.

In July 2021, Hologic announced that it had completed the acquisition of Mobidiag, a company that develops molecular diagnostic tests for infectious diseases. The acquisition is expected to help Hologic expand its offerings in the infectious disease testing market.

In May 2021, Fujifilm announced that it had completed the acquisition of Hitachi's diagnostic imaging business for $1.6 billion. The acquisition is expected to help Fujifilm expand its portfolio of medical imaging solutions and strengthen its position in the global healthcare market.

In January 2021, Philips announced that it had acquired Capsule Technologies, a leading provider of medical device integration and data technologies for hospitals and healthcare organizations. The acquisition is expected to help Philips expand its portfolio of connected care solutions.

In September 2020, Hologic announced that it had entered into a definitive agreement to acquire Biotheranostics, a company that develops molecular diagnostic tests for cancer. The acquisition is expected to help Hologic expand its offerings in the breast cancer diagnostics market.

Segmentation Analysis of The Global CRM Market 2022-2030

The report forecasts revenue growth at global, regional, and country matrics and analyzes the latest industry trends in each of the sub-segments ranging from 2016-2030. For this, CDI has segmented the global CRM market report based on capacity, vehicle, application, and propulsion type along with regional analysis. 

Product Outlook (Revenue, USD Million, 2018 - 2030)

• Film Screen Systems
• Digital Systems
• Analog Systems
• 3D Systems

Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Breast Tomosynthesis
• CAD Mammography
• Digital Mammography

End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Specialty Clinics
• Diagnosis Centers
• Others

Regional Outlook (Revenue, USD Million, 2022 - 2030)

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Nordic Countries
    • Denmark
    • Finland
    • Iceland
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America